Drug sales through retail pharmacies in 13 major markets grew 5% overall at constant exchange rates, or 3% in US$ terms, in the 12 months to July 2006, to total $377.39 billion, reports IMS Health's Retail Drug Monitor. The rate of increase shows no change from recently-reported figures for April, May or June 2006 (Marketletters passim).
The fastest-growing market was yet again Brazil, up 36% to $8.30 billion, although this continues a relative slowdown since May, while Mexico maintained growth at 13% to $7.86 billion and Argentina dipped slightly to 13% from 14% the previous month to $2.17 billion. Overall, the Latin American market's three leading players grew 22%, a slight fall in the region's overall expansion rates of 23% in June.
USA heads towards 51% of IMS markets
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze